基于网络药理学和分子对接技术探究桂枝汤治疗慢性心力衰竭的作用机制OACSTPCD
Investigating the Mechanism of Action of Guizhi Decoction in Treating Chronic Heart Failure Using Network Phar-macology and Molecular Docking Techniques
目的:使用网络药理学和分子对接技术研究探究桂枝汤对慢性心力衰竭的治疗机制.方法:通过BAT-MAN-TCM数据库筛选桂枝汤的主要有效成分和相应的靶点,利用GeneCards和DisGENET数据库确定慢性心力衰竭相关的靶基因.使用Venny平台进行中药和疾病的共同基因筛选.借助Cytoscape 3.7.2软件进行可视化处理并建立"疾病-药物-成分-靶点网络"关系图谱,以确定其中核心有效成分.运用String数据库建立蛋白质-蛋白质相互作用(PPI)网络图谱,挑选其核心靶点.运用DAVID数据库,进行基因本体(GO)功能分析以及京都基因与基因组百科全书(KEGG)通路富集分析.最后,利用Autodock软件进行核心成分和靶点的分子对接.结果:筛选出215个桂枝汤相关有效成分,共有1873个非重复的药物靶点.同时,确定了 2426个与慢性心力衰竭相关的疾病靶点,其中599个为"中药-疾病"交集基因.在"中药-疾病-有效成分-靶点"网络图中,核心有效成分包括姜酮、菖蒲酮、桦木醇、鬼伞素和壬酸.PPI网络分析得出核心靶点为AKT1、INS、IL-6、TNF和TP53.GO富集分析表明桂枝汤可能通过调节肌肉系统过程、血液循环和药物反应等途径治疗慢性心力衰竭.KEGG富集分析结果提示桂枝汤的治疗有效性可能与HIF-1信号通路、cAMP信号通路、FoxO信号通路和钙信号通路等相关.分子对接结果显示,结合能绝对值排名前三的成分分别为:桦木醇和AKT1(-5.7kcal/mol)、姜酮和IL-6(-5.5kcal/mol)、桦木醇和IL-6(-5.4kcal/mol).结论:桂枝汤的作用机制可能涉及姜酮、桦木醇、菖蒲酮、壬酸、鬼伞素等有效成分,这些成分可能通过调节HIF-1信号通路、FoxO信号通路、cAMP信号通路、钙信号通路等多条信号通路,从而影响AKT1、IL6等相关靶点,以治疗慢性心力衰竭.
OBJECTIVE:Utilizing network pharmacology and molecular docking techniques to investigate the therapeutic mechanism of Guizhi Decoction in chronic heart failure.METHODS:The main practical components and targets of Guizhi Decoc-tion were screened by the BATMAN-TCM database.We used the GeneCards and DisGENET databases to identify target genes re-lated to chronic heart failure.Using the Venny platform,we performed a joint gene screening between traditional Chinese medicine and the disease.We employed Cytoscape 3.7.2software for visual analysis,creating a"disease-drug-component-target"network diagram to identify core active components.We constructed a protein-protein interaction(PPI)network diagram using the String database to identify core targets.Subsequently,we conducted gene ontology(GO)function with Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis using the DAVID database.Finally,we utilized the Autodock software for molec-ular docking of core components and targets.RESULTS:We identified 215active components associated with Guizhi Decoction a-long with a total of 1873unique drug targets.Simultaneously,we identified 2426disease-related targets associated with chronic heart failure,with 599genes common to both traditional Chinese medicine and the disease.In the"Traditional Chinese Medicine-disease-active components-targets"network,the core active components included Zingiberone,Shyobunone,Betulin,Coprine,and Nonanoic Acid.Protein-protein interaction(PPI)network analysis revealed core targets,including AKT1,INS,IL-6,TNF,and TP53.Gene ontology(GO)enrichment analysis suggested that Guizhi Decoction may potentially treat chronic heart failure by regulating processes related to the muscular system,blood circulation,and drug responses.Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analysis results indicated that the therapeutic effectiveness of Guizhi Decoction might be associated with pathways such as HIF-1 signaling,cAMP signaling,FoxO signaling,and calcium signaling pathway.The molecu-lar docking results indicated that the top three components,based on their absolute binding energy,were betulin with AKT1(-5.7kcal/mol),Zingiberone with IL-6(-5.5kcal/mol),and botulin with IL-6(-5.4kcal/mol).Conclusion:The mechanism of action of Guizhi Decoction may involve active components such as Zingiberone,Shyobunone,Betulin,Coprine,and Nonanoic Acid.These components may potentially modulate multiple pathways,which include HIF-1 signaling pathway,FoxO signaling pathway,cAMP signaling pathway,and calcium signaling pathway.This modulation,in turn,may affect relevant targets such as AKTland IL6,offering a potential treatment approach for chronic heart failure.
陈明远;叶嘉豪;廉坤;张煜珩;胡志希
湖南中医药大学,湖南长沙 410208
临床医学
慢性心力衰竭桂枝汤网络药理学分子对接
Chronic heart failureGuizhi DecoctionNetwork pharmacologyMolecular docking
《四川中医》 2024 (004)
70-76 / 7
国家自然科学基金(编号:82274412).
评论